ArticleCancer biology & therapy2015

Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma.

Yun-Rong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.